Biovie
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -57 | -57 | -67 | -67 |
EBITDA | -7,679 | -8,506 | -10,356 | -10,664 |
EBIT | -7,737 | -8,563 | -10,423 | -10,731 |
Net Income | -8,067 | -8,401 | -10,710 | -9,111 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,851 | -5,909 | -12,177 | -11,287 |
Cash | 30,350 | 20,226 | 21,214 | 19,460 |
Basic Shares | 44,801 | 38,170 | 36,742 | 36,428 |
Annual Financials
| Values in thousands | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -266 | -237 | -229 | -229 |
EBITDA | -44,288 | -26,979 | -137,802 | -2,463 |
EBIT | -44,555 | -27,216 | -138,032 | -2,692 |
Net Income | -50,255 | -22,797 | -130,808 | -21,449 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,130 | |||
Free Cash Flow | -40,252 | -18,990 | -10,453 | -1,628 |
Cash | 19,460 | 18,641 | 4,511 | 37 |
Basic Shares | 32,483 | 24,662 | 12,403 | 4,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | -$0.22 |
2023-12-31 | -$0.22 |
2023-09-30 | -$0.29 |
2023-06-30 | -$0.25 |
